Literature DB >> 20620673

Macrophages and diabetic nephropathy.

Greg H Tesch1.   

Abstract

Evidence from renal biopsies has shown that macrophage accumulation in diabetic kidneys predicts declining renal function, suggesting a pathogenic role for these cells in diabetic nephropathy. Further evidence from animal models has shown that macrophages are the major immune cells infiltrating the kidney in type 1 and type 2 diabetes, and that they contribute to the development of renal injury and sclerosis. This review examines macrophages in human and experimental diabetic nephropathy, exploring the mechanisms of macrophage recruitment and activation, and the process of macrophage-mediated injury in diabetic kidneys. The ability of current therapies and novel anti-inflammatory treatments to reduce macrophage-mediated injury in diabetic kidneys also is considered, which has important implications for the future management of patients with diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620673     DOI: 10.1016/j.semnephrol.2010.03.007

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  33 in total

1.  Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.

Authors:  Greg Tesch; Karly C Sourris; Shaun A Summers; Domenica McCarthy; Micheal S Ward; Danielle J Borg; Linda A Gallo; Amelia K Fotheringham; Allison R Pettit; Felicia Y T Yap; Brooke E Harcourt; Adeline L Y Tan; Joshua Y Kausman; David Nikolic-Paterson; Arthur R Kitching; Josephine M Forbes
Journal:  Diabetologia       Date:  2014-06-24       Impact factor: 10.122

2.  Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.

Authors:  Yong Pan; Yi Wang; Lu Cai; Yuepiao Cai; Jie Hu; Congcong Yu; Jianling Li; Zhiguo Feng; Shulin Yang; Xiaokun Li; Guang Liang
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 3.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

4.  Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.

Authors:  Ahmed A Elmarakby; Jessica Faulkner; Babak Baban; Mohamed A Saleh; Jennifer C Sullivan
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-28

Review 5.  A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

Authors:  Yashpal S Kanwar; Lin Sun; Ping Xie; Fu-You Liu; Sheldon Chen
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

6.  Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy.

Authors:  Bryan R Conway; Jillian Rennie; Matthew A Bailey; Donald R Dunbar; Jonathan R Manning; Christopher O Bellamy; Jeremy Hughes; John J Mullins
Journal:  J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 10.121

Review 7.  Weight loss interventions and progression of diabetic kidney disease.

Authors:  Neil G Docherty; Aoife L Canney; Carel W le Roux
Journal:  Curr Diab Rep       Date:  2015-08       Impact factor: 4.810

Review 8.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

9.  Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?

Authors:  Alessandro Doria; Monika A Niewczas; Paolo Fiorina
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

10.  Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy.

Authors:  Kirti Bhatt; Linda L Lanting; Ye Jia; Sailee Yadav; Marpadga A Reddy; Nathaniel Magilnick; Mark Boldin; Rama Natarajan
Journal:  J Am Soc Nephrol       Date:  2015-12-08       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.